(Q35722883)

9 August 2017

1 reference

title

Preventing contrast nephropathy: what is the best strategy? A review of the literature (English)

1 reference

9 August 2017

1 reference

Craig D Cox

1

1 reference

9 August 2017

James P Tsikouris

series ordinal

2

1 reference

9 August 2017

publication date

1 April 2004

1 reference

The Journal of Clinical Pharmacology

9 August 2017

published in

1 reference

9 August 2017

volume

44

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

327-337

1 reference

Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Cardiology Grand Rounds from The University of North Carolina at Chapel Hill. Contrast induced nephropathy after angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Renal implications of percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Acetylcysteine and contrast agent-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Hypoxia of the renal medulla--its implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Comparative tolerability of contrast media used for coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Nephrotoxic effects in high-risk patients undergoing angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

The role of theophylline in contrast-induced nephropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Nephrotoxicity from contrast media: attenuation with theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Calcium antagonists and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Radiocontrast media-induced nephrotoxicity in patients with renal failure: rationale for a new double-blind, prospective, randomized trial testing calcium channel antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Potential deleterious effect of furosemide in radiocontrast nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Use of dopamine in prevention of contrast induced acute renal failure--a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prevention of nephrotoxicity induced by radiocontrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Comparison of iodixanol and iohexol in renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Dosing of contrast material to prevent contrast nephropathy in patients with renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Contrast nephropathy after coronary angioplasty in chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Preventive strategies in endothelin-induced renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263466

21 January 2018

Identifiers

DOI

10.1177/0091270004263466

1 reference

9 August 2017

1 reference